Skip to Main Content

Press Releases

The Benefits and Risks of the Class of Selective Serotonin Reuptake Inhibitors (SSRIs), (90 Minutes broadcast)

Date: 03.04.02

Stay Up To Date

Subscribe to receive news and insights from WTO.

Sign Up